← All companies
TYRA
Tyra Biosciences, Inc.
$32.04
-1.02 -3.09%
Key statistics
from XBRL data in SEC filingsMarket cap
$1.91B
Revenue (TTM)
—
Net income (TTM)
-$131M
EPS (TTM)
$-2.18
P/E ratio
—
Dividend yield
—
Free cash flow
-$95.3M
Cash
$85.0M
Total assets
$412M
Gross margin
—
52-week range
$9.96 – $40.65
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Shareholder vote results
Jun 2, 2026
10-Q
Quarter ended 2026-03-31
May 13, 2026
8-K
Results of operations (earnings release)
May 13, 2026
8-K
Director or officer change
Apr 17, 2026
8-K
Director or officer change
Apr 2, 2026
8-K
Other events
Mar 4, 2026
10-K
Fiscal year ended 2025-12-31
Mar 2, 2026
8-K
Results of operations (earnings release)
Mar 2, 2026
8-K
Director or officer change
Dec 1, 2025
10-Q
Quarter ended 2025-09-30
Nov 5, 2025
8-K
Results of operations (earnings release)
Nov 5, 2025
8-K
Other events
Aug 22, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Results of operations (earnings release)
Aug 14, 2025
8-K
Other events
Jun 30, 2025
8-K
Shareholder vote results
May 29, 2025
10-Q
Quarter ended 2025-03-31
May 8, 2025
8-K
Results of operations (earnings release)
May 8, 2025
10-K
Fiscal year ended 2024-12-31
Mar 27, 2025
8-K
Results of operations (earnings release)
Mar 27, 2025
8-K
Director or officer change
Jan 29, 2025
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Results of operations (earnings release)
Nov 7, 2024
8-K
Other events
Oct 28, 2024
8-K
Director or officer change; Regulation FD disclosure; Other events
Oct 25, 2024
8-K
Unregistered sale of equity
Oct 18, 2024
10-Q
Quarter ended 2024-06-30
Aug 7, 2024
8-K
Results of operations (earnings release)
Aug 7, 2024
8-K
Modified rights of security holders; Amended charter or bylaws; Shareholder vote results
May 31, 2024
10-Q
Quarter ended 2024-03-31
May 9, 2024
8-K
Results of operations (earnings release)
May 9, 2024
8-K
Director or officer change
May 7, 2024
10-K
Fiscal year ended 2023-12-31
Mar 19, 2024
8-K
Results of operations (earnings release)
Mar 19, 2024
8-K
Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure
Feb 5, 2024
8-K
Other events
Feb 1, 2024
8-K
Other events
Dec 22, 2023
10-Q
Quarter ended 2023-09-30
Nov 7, 2023
8-K
Results of operations (earnings release)
Nov 7, 2023
8-K
Amended charter or bylaws
Oct 26, 2023